Get startedLog in
    Picture of Curaleaf Holdings logo

    CURA — Curaleaf Holdings Income Statement

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Curaleaf Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    R2021
    December 31st
    R2022
    December 31st
    2023
    December 31st
    R2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1,1961,2751,3471,3341,268
    Cost of Revenue
    Gross Profit570626614641631
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Total Operating Expenses1,1731,2931,3691,3641,250
    Operating Profit22.7-17.4-22.1-29.218.1
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-62.2-86.5-124-113-78.2
    Provision for Income Taxes
    Net Income After Taxes-215-265-239-212-202
    Minority Interest
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income-206-370-281-215-231
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-206-370-281-215-231
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.257-0.288-0.251-0.233-0.26